Physician

Christina Koo Speirs, MD PHD

According to 2025 Medicare claims, Christina Speirs, MD PHD (NPI: 1386934495) practices radiation oncology in the Urban Honolulu, HI market, with the plurality of this provider's patient population coming from Honolulu, HI. This provider's primary affiliated billing organization is CANCER CENTER OF HAWAII, LLC (NPI: 1285746636; TIN: 201497111) and primary practice location at 96817-1605.

Speirs' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 372 traditional Medicare patients, billed 3,901 HCPCS/CPT codes, and received $497,329 in Medicare payments. The top billing code was G6015 (Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session). Part D data shows 298 prescription claims across 145 beneficiaries totaling $6,578 in drug costs, led by Fluocinonide (Fluocinonide). Open Payments data shows 5 records totaling $477. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $3,573 to $6,578. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	252	2,752	$390,913
2018	340	4,656	$636,982
2019	321	3,849	$500,369
2020	349	4,232	$596,144
2021	369	4,866	$674,748
2022	369	4,142	$571,869
2023	352	3,916	$519,931
2024	372	3,901	$497,329

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	31	61	$3,573
2016	23	52	$2,185
2017	58	121	$4,595
2018	74	132	$5,087
2019	91	188	$7,305
2020	99	229	$9,641
2021	117	311	$9,629
2022	117	281	$8,434
2023	101	234	$7,133
2024	145	298	$6,578

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G6015	Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session	133	549	$310
77336	Continuing radiation therapy consultation per week	103	157	$75
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	101	125	$66
77014	Ct guidance for insertion of radiation therapy fields	102	770	$51
G6002	Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy	102	459	$30

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Fluocinonide	Fluocinonide	51	1,242	$1,314
Silver Sulfadiazine	Silver Sulfadiazine	39	1,540	$832
Ssd	Silver Sulfadiazine	30	1,051	$692
Mupirocin	Mupirocin	54	1,018	$384

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	5	$477	Siemens Medical Solutions USA, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Christina Koo Speirs, MD PHD?

Tedicare shows public-source Medicare data for Christina Koo Speirs, MD PHD (NPI 1386934495), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Christina Koo Speirs, MD PHD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Christina Koo Speirs, MD PHD?

Christina Koo Speirs, MD PHD is linked to CANCER CENTER OF HAWAII, LLC (billing NPI 1285746636) in the available physician profile data.

Does Christina Koo Speirs, MD PHD have Open Payments data?

Christina Koo Speirs, MD PHD has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.